California Governor Gavin Newsom has drawn sharp criticism from LGBTQ+ advocates after vetoing a major transgender health care bill that would have required insurers to cover a 12-month supply of hormone therapy at once. The move, which came as Newsom signed several other bills protecting transgender patients’ privacy, highlights the Democratic governor’s increasingly cautious approach to transgender issues amid speculation about a future presidential run.


💊 Veto on 12-Month Hormone Therapy Supply

The proposed law would have allowed pharmacists to dispense a full year’s supply of hormone therapy to transgender patients, similar to California’s 2016 policy allowing a year’s supply of birth control. Supporters said the bill was critical to ensuring continuous access to care, especially as clinics across the nation limit gender-affirming services under federal pressure.

Newsom, however, vetoed the measure, citing potential health care cost increases. In his statement, he wrote that the state must be careful “not to enact policies that further drive up the cost of health care, no matter how well-intended.”

Independent analysts found that the bill’s financial impact would have been negligible, estimating no long-term rise in health care utilization or insurance premiums.


🏛 Political Context: Balancing Liberal Roots and Centrist Ambitions

Newsom’s decision reflects a broader strategic shift. Once celebrated for his progressive stances — including his early support for same-sex marriage as San Francisco mayor — he now faces pressure to appear more moderate. Political observers say the veto is part of an effort to appeal to swing voters while maintaining support among progressives.

“Newsom knows this decision risks angering his base,” said one political analyst, “but it may make him more acceptable to independents and centrist Democrats.”

Earlier this year, Newsom sparked backlash after saying on his podcast that transgender athletes competing in women’s sports was “deeply unfair.” He also described transgender issues as a “major problem for the Democratic Party,” claiming that Donald Trump’s campaign ads on the topic were “devastating” for Democrats in 2024.


⚖️ Reactions from Advocates and Lawmakers

State Senator Caroline Menjivar, who authored the bill, called it “the most tangible and effective way to protect transgender health care access this year.” She expressed disappointment, saying the veto undermines efforts to support communities facing “targeted discrimination.”

LGBTQ+ leaders accused Newsom of backing away from his long-standing advocacy. “He doesn’t want to face criticism while preparing for a possible presidential campaign,” said Ariela Cuellar of the California LGBTQ Health and Human Services Network.

Shannon Minter, legal director of the National Center for LGBTQ Rights, described the veto’s economic reasoning as “not plausible,” noting that the governor’s choice sends a troubling message. “This was a moment to lead with empathy and policy, not political calculation,” Minter said.


🏥 Growing Pressure on Gender-Affirming Care

Since the Trump administration began restricting gender-affirming health services, several major medical centers — including Stanford Medicine, Children’s Hospital Los Angeles, and Kaiser Permanente — have scaled back or eliminated care for patients under 19. The chilling effect has been felt even in California, one of the most progressive states in the nation.

While California law already mandates coverage for gender-affirming care, pharmacists are currently limited to dispensing a 90-day supply of hormone therapy. The vetoed bill aimed to expand that limit to one year, helping reduce interruptions for transgender, menopausal, and cancer patients who rely on consistent hormone treatment.


🧠 The Human Impact

For patients like Jovan Wolf, a transgender man and military veteran, the veto feels deeply personal. After a two-year break from testosterone therapy, Wolf sought to restart treatment earlier this year but faced bureaucratic and political roadblocks.

“Having estrogen pumping through my body is not a good feeling, physically or mentally,” he said. “When I’m on testosterone, I feel balanced. It should be my decision and my decision only.”


🔮 Looking Ahead

Newsom’s veto underscores a growing challenge for Democrats navigating transgender rights in a polarized political climate. His balancing act between progressive ideals and centrist appeal could shape both his national image and the future of LGBTQ+ health care policy in California.

As trans rights face increasing federal pushback, advocates warn that hesitation at the state level — even from historically supportive leaders — risks undoing decades of progress.


Keywords: Gavin Newsom, transgender health care, hormone therapy, California politics, LGBTQ rights, gender-affirming care, health insurance, Menjivar bill, Newsom veto, trans rights USA

By 周 恭介

專業定位: SEO、AEO(Answer Engine Optimization)、GEO(Generative Engine Optimization)、Google Ads、Facebook Ads、內容行銷、AI 搜尋策略與運動產業內容分析專家。 長期投入搜尋引擎優化、生成式 AI 搜尋、內容行銷與數位廣告領域,專注研究 AI 時代下的流量變化與品牌曝光策略,擅長將複雜的搜尋演算法、使用者需求與行銷數據整理成可執行的策略架構,協助企業提升自然流量、AI 搜尋能見度與整體數位行銷成效。 同時長期關注全球運動產業發展,持續研究 NBA、國際足球、撞球運動與體育媒體趨勢,透過數據分析、賽事觀察與產業研究,提供兼具專業性與市場觀點的運動內容解析。 專長領域: 具備多年網站經營、搜尋引擎優化與數位廣告實戰經驗,專注於 AI 搜尋趨勢、品牌成長策略與運動內容研究。

發佈留言

發佈留言必須填寫的電子郵件地址不會公開。 必填欄位標示為 *